Arcus Biosciences (RCUS) Other Gross PP&E Adjustments: 2017-2024
Historic Other Gross PP&E Adjustments for Arcus Biosciences (RCUS) over the last 5 years, with Dec 2024 value amounting to $61.0 million.
- Arcus Biosciences' Other Gross PP&E Adjustments changed negligibly% to $61.0 million in Q4 2024 from the same period last year, while for Dec 2024 it was $61.5 million, marking a year-over-year increase of 159.22%. This contributed to the annual value of $61.0 million for FY2024, which is negligibly% changed negligibly from last year.
- Arcus Biosciences' Other Gross PP&E Adjustments amounted to $61.0 million in Q4 2024, which was down 0.00% from $61.0 million recorded in Q4 2023.
- In the past 5 years, Arcus Biosciences' Other Gross PP&E Adjustments ranged from a high of $61.0 million in Q4 2023 and a low of -$104.3 million during Q2 2022.
- Moreover, its 3-year median value for Other Gross PP&E Adjustments was -$30.3 million (2022), whereas its average is -$24.3 million.
- As far as peak fluctuations go, Arcus Biosciences' Other Gross PP&E Adjustments plummeted by 8,342.33% in 2021, and later surged by 164.65% in 2022.
- Quarterly analysis of 5 years shows Arcus Biosciences' Other Gross PP&E Adjustments stood at $8.5 million in 2020, then crashed by 865.59% to -$65.0 million in 2021, then skyrocketed by 164.65% to $42.0 million in 2022, then skyrocketed by 45.24% to $61.0 million in 2023, then remained steady at $61.0 million in 2024.
- Its last three reported values are $61.0 million in Q4 2024, $61.0 million for Q4 2023, and $42.0 million during Q4 2022.